These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 21055937

  • 1. Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice.
    Piers AT, Lavin T, Radley-Crabb HG, Bakker AJ, Grounds MD, Pinniger GJ.
    Neuromuscul Disord; 2011 Feb; 21(2):132-41. PubMed ID: 21055937
    [Abstract] [Full Text] [Related]

  • 2. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.
    Radley HG, Davies MJ, Grounds MD.
    Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402
    [Abstract] [Full Text] [Related]

  • 3. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.
    Hodgetts S, Radley H, Davies M, Grounds MD.
    Neuromuscul Disord; 2006 Oct; 16(9-10):591-602. PubMed ID: 16935507
    [Abstract] [Full Text] [Related]

  • 4. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF, Mantuano P, Cozzoli A, Sanarica F, Massari AM, Conte E, Fonzino A, Giustino A, Rolland JF, Quaranta A, De Bellis M, Camerino GM, Grange RW, De Luca A.
    J Appl Physiol (1985); 2017 Apr 01; 122(4):828-843. PubMed ID: 28057817
    [Abstract] [Full Text] [Related]

  • 5. A single 30 min treadmill exercise session is suitable for 'proof-of concept studies' in adult mdx mice: a comparison of the early consequences of two different treadmill protocols.
    Radley-Crabb H, Terrill J, Shavlakadze T, Tonkin J, Arthur P, Grounds M.
    Neuromuscul Disord; 2012 Feb 01; 22(2):170-82. PubMed ID: 21835619
    [Abstract] [Full Text] [Related]

  • 6. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.
    Grounds MD, Torrisi J.
    FASEB J; 2004 Apr 01; 18(6):676-82. PubMed ID: 15054089
    [Abstract] [Full Text] [Related]

  • 7. Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers.
    Quinlan JG, Wong BL, Niemeier RT, McCullough AS, Levin L, Emanuele M.
    Neuromuscul Disord; 2006 Dec 01; 16(12):855-64. PubMed ID: 17118658
    [Abstract] [Full Text] [Related]

  • 8. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
    De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Fraysse B, Mirabella M, Servidei S, Rüegg UT, Conte Camerino D.
    J Pharmacol Exp Ther; 2003 Jan 01; 304(1):453-63. PubMed ID: 12490622
    [Abstract] [Full Text] [Related]

  • 9. Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice.
    Radley HG, Grounds MD.
    Neurobiol Dis; 2006 Aug 01; 23(2):387-97. PubMed ID: 16798005
    [Abstract] [Full Text] [Related]

  • 10. Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice.
    Whitehead NP, Streamer M, Lusambili LI, Sachs F, Allen DG.
    Neuromuscul Disord; 2006 Dec 01; 16(12):845-54. PubMed ID: 17005404
    [Abstract] [Full Text] [Related]

  • 11. Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion.
    Gosselin LE, Barkley JE, Spencer MJ, McCormick KM, Farkas GA.
    Muscle Nerve; 2003 Sep 01; 28(3):336-43. PubMed ID: 12929194
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The physiological effects of IGF-1 (class 1:Ea transgene) over-expression on exercise-induced damage and adaptation in dystrophic muscles of mdx mice.
    Ridgley JA, Pinniger GJ, Hamer PW, Grounds MD.
    Pflugers Arch; 2009 Mar 01; 457(5):1121-32. PubMed ID: 18726613
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Weekly oral prednisolone improves survival and strength in male mdx mice.
    Keeling RM, Golumbek PT, Streif EM, Connolly AM.
    Muscle Nerve; 2007 Jan 01; 35(1):43-8. PubMed ID: 16969833
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.